Hercules Capital Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Hercules Capital wird ein jährliches Gewinn- und Umsatzwachstum von 2.3% bzw. 8.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich sinken um 4.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.1% betragen.
Wichtige Informationen
2.3%
Wachstumsrate der Gewinne
-4.7%
EPS-Wachstumsrate
Capital Markets Gewinnwachstum | 14.0% |
Wachstumsrate der Einnahmen | 8.4% |
Zukünftige Eigenkapitalrendite | 16.1% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 25 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 18Recent updates
Hercules Capital: A Premium Company, But Better To Wait Until Interest Rates Decrease
Jun 07Hercules Capital: Solid 10% Yield, But Sky-High Valuation
May 10Hercules Capital: VC-Focused Name With Less Risk And Better Return Prospects Than Average BDC
May 04Hercules Capital: Winning Option In The Financial Services Space
Apr 24There Is A Reason Hercules Capital, Inc.'s (NYSE:HTGC) Price Is Undemanding
Apr 22Hercules Capital: Record Year In 2023, 10% Yield
Mar 29Unlocking Hercules Capital's Income Potential: A Fresh Look At Dividend Timing Strategies
Feb 23Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 18Hercules Capital: Still Resilient With Solid Prospects Despite The VC Focus
Feb 17Hercules Capital: A Different Type Of VC-Focused BDC
Jan 16Hercules Capital Poised For Potential Market Surge In 2024
Dec 24Lacklustre Performance Is Driving Hercules Capital, Inc.'s (NYSE:HTGC) Low P/E
Dec 1810%-Yielding Hercules Capital: Better Ingredients, Better Outcomes
Dec 15Main Street Capital Vs. Hercules Capital: Why Choose?
Nov 22Hercules Capital: 10% Yield, My Largest BDC Position
Nov 1310%-Yielding Hercules Capital Is A BDC Superstar
Oct 10Hercules Capital: Venture Capital Financier Offering High Yield And Robust Balance Sheet
Sep 17Hercules Capital: 10% Yield, Strong Coverage, Low Leverage
Sep 09Let's Build A Bond Portfolio Together: Hercules Capital Bonds 2026 7.10%
Aug 15Hercules Capital: Fatter Yield, Surging Stock Price
Aug 05Hercules Capital: The Tide Is Turning - Buy While It's Cheap (Rating Upgrade)
Jun 28Hercules Capital raises dividend by 8.3% to $0.39/share, supplemental cash distribution of $0.08
Feb 14Hercules Capital: 2 Top Reasons To Buy This 10.1%-Yielding BDC
Jan 25Should You Buy Hercules Capital Before Or After Its Ex-Dividend Date?
Jan 11Hercules Capital: Bear Market Rally Fizzling Out
Dec 08Oak Street Health secures $300M in financing
Nov 16Hercules Capital: Double Your Cash Flow With This 10%+ Dividend
Nov 07Hercules Capital raises dividend by 2.9% to $0.36, supplemental cash distribution of $0.15
Oct 18Hercules Capital: Grab Its 13% Yield As Weak Holders Capitulate
Oct 03Hercules Capital: 10% Yield, Wake Up And Smell The Cash Flow
Aug 31Hercules Capital: 7% From An Investment Grade Bond With 4 Years To Maturity
Aug 23atai Life Sciences nabs $175M in loan facility from Hercules Capital
Aug 15Hercules Capital raises dividend by 6% to $0.35 , supplemental cash distribution of $0.15
Jul 26Hercules Capital: 14% Yield, Benefits From Rising Rates, Good Upside Potential
Jul 03Buy The Dip And Position For Higher Rates With Hercules Capital
Jun 02Hercules Capital: Buy This Fat 9.7% Yield While It's On Sale
May 24Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2025 | 553 | 345 | N/A | N/A | 8 |
12/31/2024 | 509 | 341 | N/A | N/A | 8 |
3/31/2024 | 477 | 331 | -93 | -92 | N/A |
12/31/2023 | 461 | 334 | 67 | 68 | N/A |
9/30/2023 | 438 | 277 | -128 | -128 | N/A |
6/30/2023 | 406 | 302 | -66 | -65 | N/A |
3/31/2023 | 362 | 197 | -317 | -317 | N/A |
12/31/2022 | 322 | 100 | -425 | -425 | N/A |
9/30/2022 | 294 | 42 | -260 | -260 | N/A |
6/30/2022 | 280 | 12 | -166 | -166 | N/A |
3/31/2022 | 277 | 105 | -10 | -10 | N/A |
12/31/2021 | 281 | 172 | 129 | 129 | N/A |
9/30/2021 | 284 | 319 | 260 | 260 | N/A |
6/30/2021 | 284 | 339 | 208 | 208 | N/A |
3/31/2021 | 282 | 318 | 182 | 182 | N/A |
12/31/2020 | 287 | 226 | 208 | 208 | N/A |
9/30/2020 | 283 | 120 | -38 | -38 | N/A |
6/30/2020 | 281 | 96 | -2 | -2 | N/A |
3/31/2020 | 283 | 83 | -124 | -124 | N/A |
12/31/2019 | 268 | 173 | -241 | -241 | N/A |
9/30/2019 | 254 | 111 | -361 | -360 | N/A |
6/30/2019 | 238 | 128 | -407 | -407 | N/A |
3/31/2019 | 218 | 132 | -454 | -454 | N/A |
12/31/2018 | 208 | 76 | -249 | -249 | N/A |
9/30/2018 | 201 | 111 | -211 | -210 | N/A |
6/30/2018 | 194 | 109 | -180 | -180 | N/A |
3/31/2018 | 193 | 90 | 33 | 33 | N/A |
12/31/2017 | 191 | 78 | N/A | -18 | N/A |
9/30/2017 | 188 | 74 | N/A | -3 | N/A |
6/30/2017 | 187 | 72 | N/A | 11 | N/A |
3/31/2017 | 182 | 48 | N/A | -44 | N/A |
12/31/2016 | 175 | 67 | N/A | -138 | N/A |
9/30/2016 | 167 | 67 | N/A | -94 | N/A |
6/30/2016 | 169 | 41 | N/A | -16 | N/A |
3/31/2016 | 164 | 34 | N/A | -83 | N/A |
12/31/2015 | 157 | 41 | N/A | -114 | N/A |
9/30/2015 | 155 | 48 | N/A | -71 | N/A |
6/30/2015 | 145 | 59 | N/A | -160 | N/A |
3/31/2015 | 140 | 69 | N/A | -176 | N/A |
12/31/2014 | 144 | 70 | N/A | -27 | N/A |
9/30/2014 | 140 | 74 | N/A | 65 | N/A |
6/30/2014 | 144 | 96 | N/A | 150 | N/A |
3/31/2014 | 145 | 104 | N/A | 187 | N/A |
12/31/2013 | 140 | 98 | N/A | 104 | N/A |
9/30/2013 | 134 | 98 | N/A | -101 | N/A |
6/30/2013 | 117 | 66 | N/A | -245 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: HTGCDas prognostizierte Gewinnwachstum (2.3% pro Jahr) liegt unter der Sparquote (2.4%).
Ertrag vs. Markt: HTGCDie Erträge des Unternehmens (2.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: HTGCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: HTGCDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: HTGCDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: HTGCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.1%).